Presentation TCT 2012 SDF-1: Circumventing the Application of Cell Products in Heart Failure Presenter: Warren Sherman October 22, 2012
Presentation TCT 2012 When Do I Prefer Transcarotid Alternative Access for TAVR? Presenter: Vasilis Babaliaros October 22, 2012
Presentation TCT 2012 Is Innovation in the United States on the Road to Recovery? An Interim Analysis and Critique Presenter: Elazer Edelman October 22, 2012
Presentation TCT 2012 Stroke After PCI vs. CABG (All Patients and Left Main Disease) Presenter: Tullio Palmerini October 22, 2012
Presentation TCT 2012 Industry-Sponsored vs. Investigator-Initiated Research: Similarities, Differences, and Pathways to Success Presenter: David Kandzari October 22, 2012
Presentation TCT 2012 A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic... Presenter: Martin Leon October 22, 2012
Presentation TCT 2012 What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents? Presenter: Mark Wholey October 22, 2012
Presentation TCT 2012 The Importance of Central Venous Occlusion, Techniques for Intervention, and Long-term Expectation of Outcomes Presenter: Michael Dake October 22, 2012
Presentation TCT 2012 The Importance of Frailty Assessments in TAVR Patient Selection: Phenotype Description, Measurement Tools, and Impact on Clinical Outcomes Presenter: Philip Green October 22, 2012